Prot #MVT-601-056: Relugolix Versus Leuprolide in Patients with Prostate Cancer: A Randomized, Open-Label Study to Assess Major Adverse Cardiovascular Events (REPLACE-CV)

Project: Research project

Project Details

StatusActive
Effective start/end date12/20/22 → 12/20/25

Funding

  • United BioSource LLC (Prot #MVT-601-056)
  • Myovant Sciences GmbH (Prot #MVT-601-056)